Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical tr…
An institutional-grade, numbers-driven thesis on CYPH — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates Cypherpunk Technologies Inc. (CYPH) 55/100 with a 12-month base-case forecast of $5.50 — +725.8% versus the current price of $0.67. Cypherpunk Technologies Inc. trades at $0.67 in the Healthcare sector, with a market capitalisation of $37.7M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for CYPH is $5.50, implying +725.8% versus the current price. The model's 12-month scenario range runs from $1.03 (bear) to $1.15 (bull), with a base case of $1.08.
On the fundamentals, Cypherpunk Technologies shows a P/E of -33.3, trailing revenue of $1.5M, revenue growth of +0.0% YoY. This page also tracks CYPH's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
CYPH currently carries a TradersQuant composite score of 55/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $5.50 implies +725.8% from $0.67. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for CYPH is $5.50, about +725.8% versus the latest price of $0.67. Consensus is based on 7 analysts.
TradersQuant's 12-month model forecast for CYPH is a base case of $1.08, ranging from $1.03 (bear) to $1.15 (bull), an expected return of +61.7%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for CYPH over the next 12 months is $1.08 in the base case (bear $1.03, bull $1.15), versus today's price of $0.67. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for CYPH — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates CYPH's fair value at $5.50, implying +725.8% of expected upside versus the current price.
Cypherpunk Technologies does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
